PAN India Service 

WHO Certified

BREAKING NEWS. Entering into the specialty Devices business. Our Pharmacy Services For All Your Specialty Drugs & Devices need. If you have requirement of specialty medicines/device. do not look beyond VHSPL. images : source fiercepharma.

Read more

  Pioneer in the India Health Care Supply Chain Segment to become the most Advanced, Accurate, Transparent & Compliant Pharma Service Provider, with its Cutting Edge IOT Based Technology Platform – VHS LogiX. A Real Time Data Managed Service Offering Platform. An IOT Enabled Supply Chain Management Technology Platform called VHS LogiX is built & …

Read more

Billion $ info… Worldwide drug in clinical trials YES Indication. YES Phase wise. YES Conducted by YES Contact no & mail id with the address of trial done by YES Sponsor. YES Molecule launching year ???? Contact us. courtesy centrewatch

Read more

• Today, ensuring Cold Chain Products are continuously stored, handled and transported under adequate environmental conditions (temperature) is crucial. • Automated Monitoring Systems now enable to monitor and track storage and transport conditions throughout the Supply Chain up to the end-users.

Read more

Latest news sub : Biologics FDA chief says pharmas use rebates to block biosimilar competition Gottlieb: If Americans could have bought FDA-approved biosimilars last year, they could have saved more than $4.5 billion.  

Read more

Blood-based Tumour Mutational Burden Assay Predicts Clinical Benefit in NSCLC Patients Treated with Atezolizumab

I. Blood-based Tumour Mutational Burden Assay Predicts Clinical Benefit in NSCLC Patients Treated with Atezolizumab Results based on retrospective analysis of two large randomised trials. Date: 17 Aug 2018 II. Eisai, Merck take on Bayer's Nexavar with new liver cancer nod for Lenvima. Aug 17, 2018 10:15 am

Read more Blood-based Tumour Mutational Burden Assay Predicts Clinical Benefit in NSCLC Patients Treated with Atezolizumab